While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...
Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...
US stocks look set to open lower in Friday's trading session but are still in a position to close out the week higher for the first time in over a month. The Dow Jones Industrial Average futures ...